Oxaprozin
COXANTO, Daypro
Nonsteroidal Anti-inflammatory Drug
NADAC/unit
$0.5951
No Shortage
Tier 1: 4.6%
4 Manufacturers
4 ANDAs
Oxaprozin reduces pain, inflammation, and fever by inhibiting prostaglandin synthesis.
vs. brand COXANTO: Generic saves up to 94% per unit
Active Shortages
2025-07-17 Discontinuation of the manufacture of the drug., Hospira, Inc., a Pfizer Company
Generic Manufacturers
AMNEAL PHARMACEUTICALS CO GMBHCHARTWELL LIFE MOLECULES LLCDR REDDYS LABORATORIES LTDPANGEA PHARMACEUTICALS LLCPFIZER INCSOLUBIOMIX LLC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.